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Editorial
Transcatheter Device Closure of Atrial Septal  
Defects in Small Children: Sound Judgment is Key!
Henri Justino
T he inceptive report of nonoperative closure of atrial septal defects (ASD) by King and Mills1, in 1974, ushered an era of tremendous evolution 
in transcatheter device closure of secundum ASDs. 
Their pioneering efforts were responsible for much of 
the knowledge we now possess: they established the 
balloon sizing technique, described assessment of the 
septal rim adjacent to the atrioventricular valves using 
angiography (in order to exclude atrioventricular septal 
defects), and achieved successful defect closure despite 
a non-self-centering double umbrella device that required 
a saphenous vein cutdown and a 23 F delivery system! 
Since then, there has been improved understanding of 
the role of atrial septal anatomy in selection of patients 
for this procedure, including the measurement of sep-
tal length and assessment of all rims surrounding the 
defect.2 Furthermore, today’s devices have undergone 
major design enhancements to improve their deliver-
ability and retrievability, and their delivery systems have 
much lower profiles. Finally, the selection of devices 
on the market today has greatly expanded. Together, 
these factors have resulting in device therapy essentially 
supplanting surgical closure of secundum ASDs in older 
children, teenagers, and adults.
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An exception to the widespread application of the 
se techniques remains: the case of infants and young 
children. Because ASDs are generally asymptomatic in 
early childhood, delaying transcatheter closure until 
children are larger, and device placement is technically 
less challenging, is usually acceptable. However, there 
are certain vulnerable populations that may benefit from 
early closure of an ASD, such as those exhibiting poor 
growth, those with symptoms of congestive heart failure, 
and those with chronic lung disease of prematurity. 
Abolition of a left to right shunt has been shown to 
improve lung function in children with bronchopulmo-
nary dysplasia, even allowing ventilator-dependent 
patients to be successfully extubated.3-5
In the current issue of Revista Brasileira de Car-
diologia Invasiva, Ribeiro et al.6 have reported on 
transcatheter closure of ASDs in children weighing 
less than 20 kg. Theirs is a vast experience, totaling 
80 patients over a span of 15 years, and utilizing a 
wide variety of devices. They are to be commended 
for achieving successful closure in all 80 patients, with 
an extremely low complication rate. Their methodical 
approach to assessment of rims, septal length, and de 
tection of multiple fenestrations, is certainly key to 
their success. However, it must be noted that they very 
rightly excluded patients with deficient rims (except the 
retro-aortic rim), or those having a defect potentially 
requiring a device deemed too large for the child’s 
heart or those in whom a device would likely interfere 
with surrounding cardiac structures such as the superior 
vena cava, pulmonary veins, atrioventricular valves, or 
coronary sinus. Without knowing the total number of 
patients that they evaluated for potential ASD device 
closure, it is difficult to know what the success rate 
would be among the entire denominator of patients 
< 20 kg with secundum ASDs. Nevertheless, the mes-
sage is clear: with proper patient selection, currently 
available devices can achieve a high success rate with 
a very low risk of device embolization, permanent heart 
block, erosion, or surgical device removal.
Our experience is similar to that of Ribeiro et 
al.6. We recently published our data regarding device 
closure of ASDs in children < 4 years old.7 Over a 10 
year period, we had 61 children present to the cardiac 
catheterization laboratory at Texas Children’s Hospital 
(Houston, Texas, USA) for possible device closure of an 
ASD, of which almost 20% had concomitant chronic 
lung disease. We analyzed all patients referred for 
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device closure regardless of defect size, adequacy of 
rims, or the presence of multiple defects. Of the entire 
cohort, 48 (79%) underwent successful closure with a 
device. Of the 13 patients that were not deemed good 
candidates for device closure, 5 were excluded based 
on the anatomical features of the ASD on transesopha-
geal echocardiographic (TEE) imaging alone, 3 were 
excluded after balloon sizing demonstrated a defect 
too large to close safely with a device, and 5 were 
ex cluded after attempted placement of a device that 
resulted in an unfavorable appearance on TEE with 
subsequent device removal prior to release. We then 
sought to understand what factors were responsible 
for successful vs. unsuccessful device closure in this 
young population. Although both groups had similar 
weight and body surface area, comparison of the 48 
patients who underwent successful device closure 
with the 13 with unsuccessful closure revealed some 
important differences: the absolute ASD diameter was 
significantly larger among those who did not undergo 
successful device closure (16.2 ± 5.6 mm) vs. those 
with successful closure (12.8 ± 4.1 mm; P < 0.01), 
as was the ASD diameter indexed to body weight and 
body surface area, and the ratio of the ASD diameter 
to the total septal length. 
So, when considering device closure of an atrial 
septal defect in a small child, the directive should be, as 
always: primum non nocere! If the child does not have 
chronic lung disease, or exhibit symptoms of congestive 
heart failure or impaired growth, there is little to be 
gained from a precocious procedure to attempt ASD 
device closure. But as Ribeiro al.6 have elegantly and 
judiciously shown, in well-selected candidates who meet 
indications for an early device closure, a high success 
rate at minimal risk are indeed possible. These authors 
are to be lauded for their sensible and methodical 
approach to this challenging patient population. After 
all, it is imperative for interventional cardiologists to 
be mindful of the fact that a catheter-based approach 
to repair of congenital heart disease must not be riskier 
than the conventional surgical approach! We must con-
tinually strive to demonstrate that when good judgment 
is applied, the percutaneous approach does more than 
save the patient from a scar: it enhances safety.
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